S100A4 and malignant colon neoplasm: The most probable mechanism is methylation of the S100A4 promoter in normal cells, which efficiently prevents S100A4 expression, while the promoter is often hypomethylated in cancer cells, as has been observed in colon cancer cells (Chen et al., 2011).